Mouse models for mitochondrial disease
- 1 March 2001
- journal article
- review article
- Published by Wiley in American Journal of Medical Genetics
- Vol. 106 (1), 71-93
- https://doi.org/10.1002/ajmg.1393
Abstract
Mutations in mitochondrial genes encoded by both mitochondrial DNA (mtDNA) and nuclear DNA (nDNA) genes have been implicated in a wide range of neuromuscular diseases. MtDNA base substitution and rearrangement mutations generally inactivate one or more tRNA or rRNA genes and can cause myopathy, cardiomyopathy, cataracts, growth retardation, diabetes, etc. nDNA mutations can cause Leigh syndrome, cardiomyopathy, and nephropathy, due to defects in oxidative phosphorylation (OXPHOS) enzyme complexes; cartilage‐hair hypoplasia (CHH) and mtDNA depletion syndrome, through defects in mitochondrial nucleic acid metabolism; and ophthalmoplegia with multiple mtDNA deletions, caused by adenine nucleotide translocator‐1 (ANT1) mutations. Mouse models have been prepared that recapitulate a number of these diseases. The mtDNA 16S rRNA chloramphenicol (CAP) resistance mutation was introduced into the mouse female germline and caused cataracts and rod and cone abnormalities in chimeras and neonatal lethal myopathy and cardiomyopathy in mutant animals. A mtDNA deletion was introduced into the mouse germline and caused myopathy, cardiomyopathy, and nephropathy. Conditional inactivation of the nDNA mitochondrial transcription factor (Tfam) gene in the heart resulted in neonatal lethal cardiomyopathy, while its inactivation in the pancreatic β‐cells caused diabetes. The ATP/ADP ratio was implicated in mitochondrial diabetes through transgenic modification of the β‐cell ATP‐sensitive K+ channel (KATP). Mutational inactivation of the mouse Ant1 gene resulted in myopathy, cardiomyopathy, and multiple mtDNA deletions in association with elevated reactive oxygen species (ROS) production. Inactivation of uncoupler proteins (Ucp) 1–3 revealed that mitochondrial Δψ regulated ROS production. The role of mitochondrial ROS toxicity in disease and aging was confirmed by inactivating glutathione peroxidase (GPx1), resulting in growth retardation, and by total and partial inactivation of Mn superoxide dismutase (MnSOD; Sod2), resulting in neonatal lethal dilated cardiomyopathy and accelerated apoptosis in aging, respectively. The importance of mitochondrial ROS in degenerative diseases and aging was confirmed by treating Sod2 −/− mice and C. elegans with catalytic antioxidant drugs.Keywords
This publication has 227 references indexed in Scilit:
- The mitochondrial permeability transitionBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1995
- Addition of a 29 Residue Carboxyl-terminal Tail Converts a Simple HMG Box-containing Protein into a Transcriptional ActivatorJournal of Molecular Biology, 1995
- Modelling the effects of age-related mtDNA mutation accumulation; Complex I deficiency, superoxide and cell deathBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 1995
- A Human Pseudoautosomal Gene Encodes the ANT3 ADP/ATP Translocase and Escapes X-InactivationGenomics, 1993
- Fatal infantile liver failure associated with mitochondrial DNA depletionThe Journal of Pediatrics, 1992
- Porin interaction with hexokinase and glycerol kinase: Metabolic microcompartmentation at the outer mitochondrial membraneBiochemical Medicine and Metabolic Biology, 1991
- Human uncoupling protein gene: Structure, comparison with rat gene, and assignment to the long arm of chromosome 4Journal of Cellular Biochemistry, 1990
- A human ADP/ATP translocase gene has seven pseudogenes and localizes to chromosome XSomatic Cell and Molecular Genetics, 1990
- Loss of brown adipose tissue uncoupling protein mRNA on deacclimation of cold-exposed ratsBiochemical and Biophysical Research Communications, 1987
- A new syndrome of refractory sideroblastic anemia with vacuolization of marrow precursors and exocrine pancreatic dysfunctionThe Journal of Pediatrics, 1979